{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,17]],"date-time":"2026-08-17T15:33:36Z","timestamp":1786980816115,"version":"build-2736575974"},"reference-count":36,"publisher":"Springer Science and Business Media LLC","issue":"2","license":[{"start":{"date-parts":[[2021,8,26]],"date-time":"2021-08-26T00:00:00Z","timestamp":1629936000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2021,8,26]],"date-time":"2021-08-26T00:00:00Z","timestamp":1629936000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Int J Cardiovasc Imaging"],"published-print":{"date-parts":[[2022,2]]},"DOI":"10.1007\/s10554-021-02389-8","type":"journal-article","created":{"date-parts":[[2021,8,26]],"date-time":"2021-08-26T07:02:59Z","timestamp":1629961379000},"page":"271-278","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":5,"title":["Subclinic arterial and left ventricular systolic impairment in autosomal dominant polycystic kidney disease with preserved renal functions"],"prefix":"10.1007","volume":"38","author":[{"given":"Timur Selcuk","family":"Akpinar","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pinar","family":"Kucukdagli","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1085-5462","authenticated-orcid":false,"given":"Pelin Karaca","family":"Ozer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ekrem Bilal","family":"Karaayvaz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Burak","family":"Ince","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Oguz Kagan","family":"Bakkaloglu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Irem","family":"Sarihan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alpay","family":"Medetalibeyoglu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mustafa","family":"Altinkaynak","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Duygu Derya","family":"Uzun","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Erol","family":"Bozbora","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Murat","family":"Kose","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tevfik","family":"Ecder","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Halil","family":"Yazici","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2021,8,26]]},"reference":[{"key":"2389_CR1","doi-asserted-by":"crossref","unstructured":"Bellos I, Kontzoglou K, Perrea DN (2020) Markers of endothelial dysfunction and arterial stiffness in patients with early-stage autosomal dominant polycystic kidney disease: a meta-analysis. Int J Clin Pract. 18","DOI":"10.17504\/protocols.io.bcmfiu3n"},{"key":"2389_CR2","doi-asserted-by":"publisher","first-page":"592","DOI":"10.1161\/01.HYP.0000159190.71253.c3","volume":"45","author":"B Pannier","year":"2005","unstructured":"Pannier B, Guerin AP, Marchais SJ et al (2005) Stiffness of capacitive and conduit arteries: prognostic significance for end-stage renal disease patients. Hypertension 45:592?596","journal-title":"Hypertension"},{"key":"2389_CR3","doi-asserted-by":"publisher","first-page":"913","DOI":"10.2215\/CJN.06040710","volume":"6","author":"J Cunningham","year":"2011","unstructured":"Cunningham J, Locatelli F, Rodriguez M (2011) Secondary hyperparathyroidism: pathogenesis, disease progression, and therapeutic options. Clin J Am Soc Nephrol 6:913","journal-title":"Clin J Am Soc Nephrol"},{"key":"2389_CR4","doi-asserted-by":"publisher","first-page":"329","DOI":"10.1097\/MNH.0b013e3281ca6ffd","volume":"16","author":"S Liu","year":"2007","unstructured":"Liu S, Gupta A, Quarles LD (2007) Emerging role of fibroblast growth factor 23 in a bone- kidney axis regulating systemic phosphate homeostasis and extracellular matrix mineralization. Curr Opin Nephrol Hypertens 16:329","journal-title":"Curr Opin Nephrol Hypertens"},{"key":"2389_CR5","doi-asserted-by":"publisher","first-page":"1637","DOI":"10.1681\/ASN.2007010068","volume":"18","author":"S Liu","year":"2007","unstructured":"Liu S, Quarles LD (2007) How fibroblast growth factor 23 works. J Am Soc Nephrol 18:1637","journal-title":"J Am Soc Nephrol"},{"key":"2389_CR6","doi-asserted-by":"publisher","first-page":"2205","DOI":"10.1681\/ASN.2005010052","volume":"16","author":"O Gutierrez","year":"2005","unstructured":"Gutierrez O, Isakova T, Rhee E et al (2005) Fibroblast growth factor-23 mitigates hyperphosphatemia but accentuates calcitriol deficiency in chronic kidney disease. J Am Soc Nephrol 16:2205","journal-title":"J Am Soc Nephrol"},{"key":"2389_CR7","doi-asserted-by":"publisher","first-page":"2272","DOI":"10.1046\/j.1523-1755.2003.00328.x","volume":"64","author":"T Larsson","year":"2003","unstructured":"Larsson T, Nisbeth U, Ljunggren O et al (2003) Circulating concentration of FGF-23 increases as renal function declines in patients with chronic kidney disease, but does not change in response to variation in phosphate intake in healthy volunteers. Kidney Int 64:2272","journal-title":"Kidney Int"},{"key":"2389_CR8","doi-asserted-by":"publisher","first-page":"511","DOI":"10.1210\/jc.2008-0326","volume":"94","author":"K Wesseling-Perry","year":"2009","unstructured":"Wesseling-Perry K, Pereira RC, Wang H, Elashoff RM, Sahney S, Gales B, J\u00fcppner H, Salusky IB, (2009) Relationship between plasma fibroblast growth factor-23 concentration and bone mineralization in children with renal failure on peritoneal dialysis. J Clin Endocrinol Metab 94:511?517","journal-title":"J Clin Endocrinol Metab"},{"key":"2389_CR9","doi-asserted-by":"crossref","unstructured":"Fliser D, Kollerits B, Neyer U, Ankerst DP, Lhotta K, Lingenhel A, Ritz E, Kronenberg F, Kuen E, K\u00f6nig P, Kraatz G, Mann JF, M\u00fcller GA, K\u00f6hler H, Riegler P, (2007) Fibroblast growth factor 23 (FGF23) predicts progression of chronic kidney disease: the Mild to Moderate Kidney Disease (MMKD) Study. J Am Soc Nephrol 18:2600\u20132608","DOI":"10.1681\/ASN.2006080936"},{"key":"2389_CR10","doi-asserted-by":"crossref","unstructured":"Hsu HJ, Wu MS 2009 Fibroblast growth factor 23: a possible cause of left ventricular hypertrophy in hemodialysis patients. Am J Med Sci 337:116\u2013122","DOI":"10.1097\/MAJ.0b013e3181815498"},{"key":"2389_CR11","doi-asserted-by":"crossref","unstructured":"Gutierrez OM, Januzzi JL, Isakova T, Laliberte K, Smith K, Collerone G, Sarwar A, Hoffmann U, Coglianese E, Christenson R, Wang TJ, Defilippi C, WolfM\u00a02009. Fibroblast growth factor23 and left ventricular hypertrophy in chronic kidney disease. Circulation 119: 2545\u20132552","DOI":"10.1161\/CIRCULATIONAHA.108.844506"},{"key":"2389_CR12","first-page":"279","volume":"24","author":"G Jean","year":"2009","unstructured":"Jean G, Terrat JC, Vanel T, Hurot JM, Lorriaux C,MayorB, Chazot C (2009) High levels of serum fibroblast growth factors (FGF)-23 are associated with increased mortality in long haemodialysis patients. Nephrol Dial Transplant 24:279\u20132796","journal-title":"Nephrol Dial Transplant"},{"key":"2389_CR13","doi-asserted-by":"crossref","unstructured":"Guti\u00e9rrez OM, Mannstadt M, Isakova T, Rauh-Hain JA, Tamez H, Shah A, Smith K, Lee H, Thadhani R, J\u00fcppner H, Wolf M, (2008) Fibroblast growth factor 23 and mortality among patients undergoing hemodialysis. N Engl J Med 359:584\u2013592","DOI":"10.1056\/NEJMoa0706130"},{"key":"2389_CR14","doi-asserted-by":"crossref","unstructured":"Gilman G, Khandheria BK, Hagen ME et al, Strain rate and strain: a step-by-step approach to image and data acquisition. J Am Soc Echocardiogr. 2004; 17:1011\u20131020. 133. Helle-Valle T, Crosby J, Edvardsen T et al. New non-invasive method for assessment of left ventricular rotation: speckle tracking echocardiography. Circulation. 2005","DOI":"10.1016\/j.echo.2004.04.039"},{"issue":"1","key":"2389_CR15","doi-asserted-by":"publisher","first-page":"324","DOI":"10.1186\/s12882-019-1500-1","volume":"16","author":"MCH Lassen","year":"2019","unstructured":"Lassen MCH, Qasim AN, Biering-S\u00f8rensen T, Reeh JLT, Watnick T, Seliger SL, Chen H, Sawan MA, Nguyen D, Li Y, Hong SN, Park M (2019 Aug) Cardiac function assessed by myocardial deformation in adult polycystic kidney disease patients. BMC Nephrol 16(1):324 20(","journal-title":"BMC Nephrol"},{"key":"2389_CR16","doi-asserted-by":"publisher","first-page":"803","DOI":"10.1016\/S0272-6386(12)70338-4","volume":"22","author":"D Ravine","year":"1993","unstructured":"Ravine D, Gibson RN, Donlan J, Sheffield LJ (1993) An ultrasound renal cyst prevalence survey: specificity data for inherited renal cystic diseases. Am J Kidney Dis 22:803","journal-title":"Am J Kidney Dis"},{"key":"2389_CR17","doi-asserted-by":"publisher","first-page":"391","DOI":"10.1159\/000013382","volume":"18","author":"G Cerasola","year":"1998","unstructured":"Cerasola G, Vecchi ML, Mule G, Cottone S, Mangano MT, Andronico G et al (1998) Sympathetic activity and blood pressure pattern in autosomal dominant polycystic kidney disease hypertensives. Am J Nephrol 18:391\u2013398","journal-title":"Am J Nephrol"},{"key":"2389_CR18","unstructured":"Klein IHHT, Ligtenberg G, Oey PL, Koomans HA, Blankestijn PJ. Sympathetic activity is increased in polycystic kidney disease and is associated with hypertension. J Am Soc Nephrol"},{"key":"2389_CR19","doi-asserted-by":"publisher","first-page":"1169","DOI":"10.1681\/ASN.V971169","volume":"9","author":"B Hocher","year":"1998","unstructured":"Hocher B, Zart R, Schwarz A, Vogt V, Braun C, Thone- Reineke C et al (1998) Renal endothelin system in polycyctic kidney disease. J Am Soc Nephrol 9:1169\u20131177","journal-title":"J Am Soc Nephrol"},{"key":"2389_CR20","doi-asserted-by":"publisher","first-page":"1381","DOI":"10.1046\/j.1523-1755.2003.00236.x","volume":"64","author":"D Wang","year":"2003","unstructured":"Wang D, Iversen J, Wilcox CS, Strandgaard S (2003) Endothelial dysfunction and reduced nitric oxide in resistance arteries in autosomal dominant polycystic kidney disease. Kidney Int 64:1381\u20131388","journal-title":"Kidney Int"},{"key":"2389_CR21","doi-asserted-by":"publisher","first-page":"854","DOI":"10.1053\/j.ajkd.2004.01.011","volume":"43","author":"O Kocaman","year":"2004","unstructured":"Kocaman O, Oflaz H, Yekeler E, Dursun M, Erdogan D, Demirel S et al (2004) Endothelial dysfunction and increased carotid intima-media thickness in patients with autosomal dominant polycystic kidney disease. Am J Kidney Dis 43:854\u2013860","journal-title":"Am J Kidney Dis"},{"key":"2389_CR22","doi-asserted-by":"publisher","first-page":"1292","DOI":"10.1681\/ASN.V881292","volume":"8","author":"AB Chapman","year":"1997","unstructured":"Chapman AB, Johnson AM, Rainguet S, Hossack K, Gabow P, Schrier RW (1997) Left ventricular hypertrophy in autosomal dominant polycyctic kidney disease. J Am Soc Nephrol 8:1292\u20131297","journal-title":"J Am Soc Nephrol"},{"key":"2389_CR23","doi-asserted-by":"publisher","first-page":"2244","DOI":"10.1111\/j.1523-1755.2005.00682.x","volume":"68","author":"H Oflaz","year":"2005","unstructured":"Oflaz H, Alisir S, Buyukaydin B, Kocaman O, Turgut F, Namli S et al (2005) Biventricular diastolic dysfunction in patients with autosomal dominant polycystic kidney disease. Kidney Int 68:2244\u20132249","journal-title":"Kidney Int"},{"key":"2389_CR24","doi-asserted-by":"publisher","first-page":"965","DOI":"10.1053\/j.ajkd.2005.02.026","volume":"45","author":"A Covic","year":"2005","unstructured":"Covic A, Gusbeth-Tatomir P, Goldsmith DJ (2005) Arterial stiffness in renal patients: an update. Am JKidney Dis 45:965\u2013977","journal-title":"Am JKidney Dis"},{"key":"2389_CR25","doi-asserted-by":"publisher","first-page":"2588","DOI":"10.1093\/eurheartj\/ehl254","volume":"27","author":"S Laurent","year":"2006","unstructured":"Laurent S, Cockcroft J, Van Bortel L, Boutouyrie P, Giannattasio C, Hayoz D et al (2006) Expert consensus document on arterial stiffness: methodological issues and clinical applications. Eur Heart J 27:2588\u20132605","journal-title":"Eur Heart J"},{"key":"2389_CR26","doi-asserted-by":"publisher","first-page":"494","DOI":"10.1053\/j.ajkd.2004.11.011","volume":"45","author":"MC Wang","year":"2005","unstructured":"Wang MC, Tsai WC, Chen JY, Huang JJ (2005) Stepwise increase in arterial stiffness corresponding with the stages of chronic kidney disease. Am JKidney Dis 45:494\u2013501","journal-title":"Am JKidney Dis"},{"key":"2389_CR27","doi-asserted-by":"publisher","first-page":"1834","DOI":"10.1046\/j.1523-1755.2001.0590051834.x","volume":"59","author":"JJ Mourad","year":"2001","unstructured":"Mourad JJ, Pannier B, Blacher J, Rudnichi A, Benetos A, London GM et al (2001) Creatinine clearance, pulse wave velocity, carotid compliance and essential hypertension. Kidney Int 59:1834\u20131841","journal-title":"Kidney Int"},{"issue":"Suppl 2","key":"2389_CR28","doi-asserted-by":"publisher","first-page":"S15","DOI":"10.1177\/089686080902902S02","volume":"29","author":"MS Demirci","year":"2009","unstructured":"Demirci MS, Ozkahya M, Asci G, Sevinc E, Yilmaz M, Demirci C et al (2009) The influence of dialysate calcium on progression of arterial stiffness in peritoneal dialysis patients. Perit Dial Int 29(Suppl 2):S15\u2013S17","journal-title":"Perit Dial Int"},{"key":"2389_CR29","doi-asserted-by":"publisher","first-page":"668","DOI":"10.1177\/089686080802800621","volume":"28","author":"T Adragao","year":"2008","unstructured":"Adragao T, Branco P, Birne R, Curto JD, de Almeida E, Prata MM et al (2008) Bone mineral density, vascular calcifications, and arterial stiffness in peritoneal dialysis patients. Perit Dial Int 28:668\u2013672","journal-title":"Perit Dial Int"},{"key":"2389_CR30","doi-asserted-by":"publisher","first-page":"1713","DOI":"10.1093\/ndt\/17.10.1713","volume":"17","author":"GM London","year":"2002","unstructured":"London GM, Marchais SJ, Guerin AP, Metivier F, Adda H (2002) Arterial structure and function in end-stage renal disease. Nephrol Dial Transplant 17:1713\u20131724","journal-title":"Nephrol Dial Transplant"},{"key":"2389_CR31","unstructured":"Krishnasamy R, Hawley CM, Stanton T, Howden EJ, Beetham K, Strand H, Leano R, Haluska B, Coombes JS, Isbel NM.Association between left ventricular global longitudinal strain, health-related quality of life and functional capacity in chronic kidney disease patients with preserved ejection fraction"},{"key":"2389_CR32","unstructured":"Rathika Krishnasamy CM, Hawley T, Stanton EM, Pascoe KL, Campbell M, Rossi W, Petchey K-S, Tan KS, Beetham JS, Coombes R, Leano BA Haluska and Nicole M. Isbel Left ventricular global longitudinal strain is associated with cardiovascular risk factors and arterial stiffness in chronic kidney disease"},{"key":"2389_CR33","doi-asserted-by":"crossref","unstructured":"Faul C, Amaral AP, Oskouei B, Hu MC, Sloan A, Isakova T, Guti\u00e9rrez OM, Aguillon- Prada RJ.\u00a02011 F23 induces left ventricular hypertrophy. Clin Invest 121(11):4393 \u2013 4408","DOI":"10.1172\/JCI46122"},{"issue":"19","key":"2389_CR34","doi-asserted-by":"publisher","first-page":"2545","DOI":"10.1161\/CIRCULATIONAHA.108.844506","volume":"119","author":"OM Gutierrez","year":"2009","unstructured":"Gutierrez OM et al (2009) Fibroblast growth factor 23 and left ventricular hypertrophy in chronic kidney disease. Circulation 119(19):2545\u20132552. https:\/\/doi.org\/10.1161\/CIRCULATIONAHA.108.844506","journal-title":"Circulation"},{"issue":"2","key":"2389_CR35","doi-asserted-by":"publisher","first-page":"546","DOI":"10.1016\/j.atherosclerosis.2009.05.013","volume":"207","author":"MA Mirza","year":"2009","unstructured":"Mirza MA, Larsson A, Melhus H, Lind L, Larsson TE (2009) Serum intact FGF23 associate with left ventricular mass, hypertrophy and geometry in an elderly population. Atherosclerosis 207(2):546\u2013551. doi:https:\/\/doi.org\/10.1016\/j.atherosclerosis.2009.05.013","journal-title":"Atherosclerosis"},{"issue":"22","key":"2389_CR36","doi-asserted-by":"publisher","first-page":"1561","DOI":"10.1056\/NEJM199005313222203","volume":"322","author":"D Levy","year":"1990","unstructured":"Levy D, Garrison RJ, Savage DD, Kannel WB, Castelli WP (1990) Prognostic implications of echocardiographically determined left ventricular mass in the Framingham Heart Study. N Engl J Med 322(22):1561\u20131566. doi:https:\/\/doi.org\/10.1056\/NEJM199005313222203","journal-title":"N Engl J Med"}],"container-title":["The International Journal of Cardiovascular Imaging"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10554-021-02389-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s10554-021-02389-8\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10554-021-02389-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,3,1]],"date-time":"2022-03-01T22:07:23Z","timestamp":1646172443000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s10554-021-02389-8"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,8,26]]},"references-count":36,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2022,2]]}},"alternative-id":["2389"],"URL":"https:\/\/doi.org\/10.1007\/s10554-021-02389-8","relation":{},"ISSN":["1569-5794","1573-0743"],"issn-type":[{"value":"1569-5794","type":"print"},{"value":"1573-0743","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,8,26]]},"assertion":[{"value":"3 July 2021","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"26 August 2021","order":2,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The author(s) declared no potential conflicts of interest with respect to the research, authorship, and\/or publication of this article.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}}]}}